Debt To Equity RatioHigh Vol 1yNet Profit MarginReturn 1y
Market Capitalization35.44B CNY
Trailing P/E-142.78 CNY
52-Week Change48.52 CNY
Beta0.1170 CNY
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is a key player in the biopharmaceutical industry, specializing in the research, development, production, and distribution of biochemical medications. The company's primary focus lies in the production of heparin sodium injections, a widely used anticoagulant essential in various medical procedures and treatments. Additionally, they offer products for the treatment of cardiovascular diseases, thrombosis, and related ailments. Hebei Changshan operates with a goal to enhance health outcomes and patient care globally through their rigorous quality controls and commitment to pharmaceutical innovation. With a strong emphasis on research and development, the company significantly influences the healthcare sector by addressing critical medical needs through their innovative solutions and high-quality products. Headquartered in China, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. contributes to the global supply chain of medical treatments, underscoring its importance within the pharmaceutical landscape.
Industry
Biotechnology
Healthcare sector · China
Stories
Structural patterns identified in Hebei Changshan Biochemical Pharmaceutical Co., Ltd.